Antecedent Hyperglycemia Is Associated With an Increased Risk of Neutropenic Infections During Bone Marrow Transplantation

被引:43
作者
Derr, Rachel L. [1 ,2 ]
Hsiao, Victoria C. [1 ]
Saudek, Christopher D. [1 ,2 ]
机构
[1] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Div Endocrinol & Metab, Baltimore, MD 21205 USA
关键词
D O I
10.2337/dc08-0574
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To use bone marrow transplantation (BMT) as a model for testing the association between hyperglycemia and infection. RESEARCH DESIGN AND METHODS - This cohort study included 382 adults (6.5% with diabetes) who had no evidence of infection before neutropenia during BMT. Mean glucose was calculated from Central laboratory and bedside measurements taken before neutropenia; the primary outcome was neutropenic infections. RESULTS - Eighty-four patients (22%) developed at least one neutropenic infection, including 5 1 patients (13%) with bloodstream infections. In patients who did not receive glucocorticoids during neutropenia, each 10 mg/dl increase in mean preneutropenia glucose was associated With an odds ratio of 1.08 (95% CI 0.98-1.19) (P = 0. 14) for all), infection and 1.15 (1.03-1.28) (P = 0.01.) for bloodstream infections, after adjusting for age. sex, race, year, cancer diagnosis, transplant type, and total glucocorticoid dose before neutropenia. In those who received glucocorticoids during neutropenia (n = 71), the adjusted odds ratio associated with a 10 mg/dl increase in mean glucose was 1.21 (1.09-1.34) (P < 0.0001) for any infection and 1.24 (1.11-1.38) (P < 0.0001) for bloodstream infections. There was no association between mean glycemia and long length of hospital stay, critical status designation, or mortality. CONCLUSIONS- In a BMT population highly susceptible to infection, there was a continuous positive association between mean antecedent glycemia and later infection risk, particularly in patients who received glucocorticoids while neutropenic. Tight glycemic control during BMT and glucocorticoid treatment may reduce infections.
引用
收藏
页码:1972 / 1977
页数:6
相关论文
共 25 条
[1]   Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease [J].
Baker, EH ;
Janaway, CH ;
Philips, BJ ;
Brennan, AL ;
Baines, DL ;
Wood, DM ;
Jones, PW .
THORAX, 2006, 61 (04) :284-289
[2]   Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome [J].
Benfield, T. ;
Jensen, J. S. ;
Nordestgaard, B. G. .
DIABETOLOGIA, 2007, 50 (03) :549-554
[3]   SHORT-TERM HYPERGLYCEMIA DEPRESSES IMMUNITY THROUGH NONENZYMATIC GLYCOSYLATION OF CIRCULATING IMMUNOGLOBULIN [J].
BLACK, CT ;
HENNESSEY, PJ ;
ANDRASSY, RJ .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1990, 30 (07) :830-833
[4]  
BLACK CT, 1990, J TRAUMA, V30, P832, DOI DOI 10.1097/00005373-199007000-00012
[5]  
Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO
[6]  
2-V
[7]   Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation [J].
Fuji, Shigeo ;
Kim, Sung-Won ;
Mori, Shin-ichiro ;
Fukuda, Takahiro ;
Kamiya, Shigemi ;
Yamasaki, Satoshi ;
Morita-Hoshi, Yuriko ;
Ohara-Waki, Fusako ;
Honda, Osamu ;
Kuwahara, Setsuko ;
Tanosaki, Ryuji ;
Heike, Yuji ;
Tobinai, Kensei ;
Takaue, Yoichi .
TRANSPLANTATION, 2007, 84 (07) :814-820
[8]   Hyperglycemia and length of stay in patients hospitalized for bone marrow transplantation [J].
Garg, Rajesh ;
Bhutani, Himanshli ;
Alyea, Edward ;
Pendergrass, Merri .
DIABETES CARE, 2007, 30 (04) :993-994
[9]   Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes [J].
Golden, SH ;
Peart-Vigilance, C ;
Kao, WHL ;
Brancati, FL .
DIABETES CARE, 1999, 22 (09) :1408-1414
[10]   A CONTROLLED TRIAL OF FLUCONAZOLE TO PREVENT FUNGAL-INFECTIONS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION [J].
GOODMAN, JL ;
WINSTON, DJ ;
GREENFIELD, RA ;
CHANDRASEKAR, PH ;
FOX, B ;
KAIZER, H ;
SHADDUCK, RK ;
SHEA, TC ;
STIFF, P ;
FRIEDMAN, DJ ;
POWDERLY, WG ;
SILBER, JL ;
HOROWITZ, H ;
LICHTIN, A ;
WOLFF, SN ;
MANGAN, KF ;
SILVER, SM ;
WEISDORF, D ;
HO, WG ;
GILBERT, G ;
BUELL, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (13) :845-851